ProfileGDS5678 / 1445504_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 48% 46% 47% 47% 47% 46% 52% 44% 47% 47% 47% 48% 47% 49% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.170648
GSM967853U87-EV human glioblastoma xenograft - Control 23.089646
GSM967854U87-EV human glioblastoma xenograft - Control 33.121747
GSM967855U87-EV human glioblastoma xenograft - Control 43.055247
GSM967856U87-EV human glioblastoma xenograft - Control 53.0466847
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1866446
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.349252
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0183844
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0988547
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.101447
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.100947
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1015748
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1156947
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1575649